Official source Data mirrored from Centers for Medicare & Medicaid Services Open Payments · General Payments · as published 2026-01-23 View official record Methodology

Covered recipient · General Payments record

JORGE MARIO DIEGO

Allopathic & Osteopathic Physicians Internal Medicine Nephrology

NPI
1669400198
CMS profile
347729
Location
SHELBYVILLE, IN

General Payments · PY2018–2024

$85,230.26

  • Reported across 316 records
  • CMS publication 2026-01-23

Latest program year · PY2024

$7,943.94

31 records · 0 disputed

Financial relationships do not necessarily indicate an improper relationship; the data is open to interpretation.

How these totals are calculated
  • The total is the sum of the General Payments records CMS published for the labeled program year(s), exactly as published. Nothing is estimated, weighted, or combined across categories.
  • General Payments only. Research and Ownership/Investment are separate datasets and are never summed with these figures; amounts are kept separate per program year.
  • Featured-page threshold (a presentation gate, not a judgment): records>=3 OR total>=100 (all years).
  • Methodology & Data — sourcing, labeling, and limitations.

By nature of payment

PY2024 · sorted by reported total

By paying entity

PY2024 · sorted by reported total

By program year

All program years on this page · sorted by year

Program yearAmountRecords
PY2018 $4,793.07 36
PY2019 $33,123.72 79
PY2020 $4,650.10 24
PY2021 $11,640.22 39
PY2022 $13,225.45 56
PY2023 $9,853.76 51
PY2024 $7,943.94 31

Payment records · PY2024 (31)

Sorted by paying entity, then date · as published by CMS

Program year 2024 201820192020202120222023 Record-level detail is published for PY2024; earlier years are summarised in “By program year”.
Paying entity Amount Date Nature of payment Dispute status Published Record ID Source
ABBVIE INC. $19.83 04/27/2024 Food and Beverage Undisputed 01/23/2026 1103640726 CMS
Ardelyx, Inc. $16.60 02/02/2024 Food and Beverage Undisputed 01/23/2026 1146678349 CMS
AstraZeneca Pharmaceuticals LP $165.98 01/08/2024 Food and Beverage Undisputed 01/23/2026 1104649659 CMS
AstraZeneca Pharmaceuticals LP $17.36 01/17/2024 Food and Beverage Undisputed 01/23/2026 1105332094 CMS
AstraZeneca Pharmaceuticals LP $16.09 02/06/2024 Food and Beverage Undisputed 01/23/2026 1105679589 CMS
AstraZeneca Pharmaceuticals LP $121.18 03/12/2024 Food and Beverage Undisputed 01/23/2026 1104592394 CMS
AstraZeneca Pharmaceuticals LP $13.07 03/12/2024 Travel and Lodging Undisputed 01/23/2026 1105586686 CMS
AstraZeneca Pharmaceuticals LP $1,600.00 03/20/2024 Compensation for services other than consulting, including serving as faculty or as a speaker at a venue other than a continuing education program Undisputed 01/23/2026 1105896808 CMS
AstraZeneca Pharmaceuticals LP $100.00 04/02/2024 Compensation for services other than consulting, including serving as faculty or as a speaker at a venue other than a continuing education program Undisputed 01/23/2026 1105664148 CMS
AstraZeneca Pharmaceuticals LP $18.59 04/24/2024 Food and Beverage Undisputed 01/23/2026 1104666781 CMS
AstraZeneca Pharmaceuticals LP $13.40 04/25/2024 Travel and Lodging Undisputed 01/23/2026 1104499094 CMS
AstraZeneca Pharmaceuticals LP $131.58 04/25/2024 Food and Beverage Undisputed 01/23/2026 1105878859 CMS
AstraZeneca Pharmaceuticals LP $1,600.00 05/03/2024 Compensation for services other than consulting, including serving as faculty or as a speaker at a venue other than a continuing education program Undisputed 01/23/2026 1105601870 CMS
AstraZeneca Pharmaceuticals LP $121.60 05/16/2024 Food and Beverage Undisputed 01/23/2026 1104349094 CMS
AstraZeneca Pharmaceuticals LP $166.16 05/16/2024 Travel and Lodging Undisputed 01/23/2026 1104746493 CMS
AstraZeneca Pharmaceuticals LP $3,200.00 07/01/2024 Compensation for services other than consulting, including serving as faculty or as a speaker at a venue other than a continuing education program Undisputed 01/23/2026 1105743386 CMS
AstraZeneca Pharmaceuticals LP $17.12 09/25/2024 Food and Beverage Undisputed 01/23/2026 1104561258 CMS
Bayer Healthcare Pharmaceuticals Inc. $14.62 07/23/2024 Food and Beverage Undisputed 01/23/2026 1086137309 CMS
Boehringer Ingelheim Pharmaceuticals, Inc. $15.00 03/19/2024 Food and Beverage Undisputed 01/23/2026 1118101706 CMS
CALLIDITAS THERAPEUTICS US INC. $22.89 02/20/2024 Food and Beverage Undisputed 01/23/2026 1141509725 CMS
GlaxoSmithKline, LLC. $121.83 09/24/2024 Food and Beverage Undisputed 01/23/2026 1116636602 CMS
Lexicon Pharmaceuticals, Inc. $125.50 08/28/2024 Food and Beverage Undisputed 01/23/2026 1081718026 CMS
Novartis Pharmaceuticals Corporation $38.67 06/12/2024 Food and Beverage Undisputed 01/23/2026 1086919923 CMS
Novartis Pharmaceuticals Corporation $22.23 10/29/2024 Food and Beverage Undisputed 01/23/2026 1086919947 CMS
Novo Nordisk Inc $20.15 09/16/2024 Food and Beverage Undisputed 01/23/2026 1097212489 CMS
Novo Nordisk Inc $18.95 10/10/2024 Food and Beverage Undisputed 01/23/2026 1097485729 CMS
Novo Nordisk Inc $124.26 11/21/2024 Food and Beverage Undisputed 01/23/2026 1097521644 CMS
NXSTAGE MEDICAL, INC. $20.32 10/16/2024 Food and Beverage Undisputed 01/23/2026 1154282529 CMS
Otsuka America Pharmaceutical, Inc. $26.88 05/01/2024 Food and Beverage Undisputed 01/23/2026 1118885343 CMS
Vifor Pharma, Inc. $19.58 06/26/2024 Food and Beverage Undisputed 01/23/2026 1124050864 CMS
ViiV Healthcare Company $14.50 07/12/2024 Food and Beverage Undisputed 01/23/2026 1112726158 CMS

Source & provenance

Dataset
CMS Open Payments — General Payments
Publisher of source data
Centers for Medicare & Medicaid Services
CMS publication date
2026-01-23
Program years on this page
2018, 2019, 2020, 2021, 2022, 2023, 2024
Source files
Dataset page · Bulk file · PY2018 , PY2019 , PY2020 , PY2021 , PY2022 , PY2023 , PY2024
Generated from
OP_DTL_GNRL_PGYR2024_P01232026_01102026.csv

One page per canonical provider; split Profile_IDs are merged via Associated_Covered_Recipient_Profile_ID_1/_2 from the Covered Recipient Profile Supplement.

Corrections to the substance of a record route to CMS through its review-and-dispute process; errors in how this site mirrors or displays a record route to us. Both paths are described in Methodology & Data.